Clinical Trial Detail

NCT ID NCT01857934
Title Therapy for Children With Advanced Stage Neuroblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

neuroblastoma

Therapies

Doxorubicin

Sargramostim

Aldesleukin

Vincristine Sulfate

Filgrastim

Tretinoin

Levetiracetam

Cisplatin + Etoposide

Hu14.18K322A

Busulfan + Melphalan

Cyclophosphamide + Topotecan

Age Groups: child

No variant requirements are available.